MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pre-treatment with Methanolic Extract Mucuna pruriens Seeds Attenuates Serotonin Gene Depletion, Motor Dysfunction and Anxiogenic Responses in a Rat Model of Parkinsonism

A. Obajuluwa, B. Laoye, J. Okwuaka, T. Obajuluwa, J. Lech, A. Oremosu (Ado -Ekiti, Nigeria)

Meeting: 2024 International Congress

Abstract Number: 818

Keywords: Levodopa(L-dopa), Paraquat, Parkinsonism

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: Investigate neuroprotective and genoprotective effects of methanolic Mucuna pruriens (Mp) seed extract in a paraquat-induced Parkinsonism rat model.

Background: Paraquat exposure has been linked to the impairment of critical neurotransmitters and the pathogenesis of neurodegenerative diseases, including Parkinson’s disease (PD).Despite the use of levopoda in PD treatment, alternative treatments are sought due to side effects arising from long-term use. We assessed mRNA serotonin (5-HT) expression, fecal boli frequency, motor coordination, and anxiety symptoms in paraquat-exposed rats pre or post-treated with Mp seed extract.

Method: Male rats (200-230g) were divided into groups (n=7): A) negative control (10mg/kg distilled water), B) paraquat (10 mg/kg), C) paraquat(10mg/kg) + L-poda/sin(12mg/kg), D)pre-treated Mp(15mg/kg)+paraquat(10mg/kg), E) paraquat(10mg/kg)+ post Mp treatment(15mg/kg). Neurobehavioral assessments used were elevated plus maze, parallel beam, and open field tests while doses were administered p.o daily for 21 days. Pre-treatment groups received Mp doses a week before paraquat intubation; post-treatment groups received Mp doses a week after 14 days of paraquat intubation. Total RNA from rats’ basal ganglia was analyzed using real-time PCR for 5-HT and GAPDH. PCR products were electrophoresed on 1.2% agarose gel.

Results: All groups showed significant weight reductions (p<0.001) compared to the negative control. Real-time gene expression analysis revealed 5-HT depletion (p<0.0001) in the paraquat group, with higher levels in Mp pre-treated rats compared to other groups.Paraquat reduced locomotion and open arm entries in all groups, but Mp pre-treated rats exhibited increased motor coordination (p<0.01) and positive effects on the parallel beam (p<0.01) compared to paraquat and post-treated Mp groups.

Conclusion: Mp pre-treatment attenuates paraquat-induced PD symptoms, including anxiogenic responses, depleted 5-HT expression, and motor coordination, compared to post-treatment with Mp. Hence, early pharmacological intervention in PD management is promising, but safety assessments for Mp seed extract in neurodegenerative disorder treatment are crucial.

Fig 1

Fig 1

Fig 2

Fig 2

Fig 3

Fig 3

Fig 4

Fig 4

Fig 5

Fig 5

References: Objective: Investigate neuroprotective and genoprotective effects of methanolic Mucuna pruriens (Mp) seed extract in a paraquat-induced Parkinsonism rat model.
Background: Paraquat exposure has been linked to the impairment of critical neurotransmitters and the pathogenesis of neurodegenerative diseases, including Parkinson’s disease (PD).Despite the use of levopoda in PD treatment, alternative treatments are sought due to side effects arising from long-term use. We assessed mRNA serotonin (5-HT) expression, fecal boli frequency, motor coordination, and anxiety symptoms in paraquat-exposed rats pre or post-treated with Mp seed extract.
Methods: Male rats (200-230g) were divided into groups (n=7): A) negative control (10mg/kg distilled water), B) paraquat (10 mg/kg), C) paraquat(10mg/kg) + L-poda/sin(12mg/kg), D)pre-treated Mp(15mg/kg)+paraquat(10mg/kg), E) paraquat(10mg/kg)+ post Mp treatment(15mg/kg). Neurobehavioral assessments used were elevated plus maze, parallel beam, and open field tests while doses were administered p.o daily for 21 days. Pre-treatment groups received Mp doses a week before paraquat intubation; post-treatment groups received Mp doses a week after 14 days of paraquat intubation. Total RNA from rats’ basal ganglia was analyzed using real-time PCR for 5-HT and GAPDH. PCR products were electrophoresed on 1.2% agarose gel.
Results: All groups showed significant weight reductions (p<0.001) compared to the negative control. Real-time gene expression analysis revealed 5-HT depletion (p<0.0001) in the paraquat group, with higher levels in Mp pre-treated rats compared to other groups.Paraquat reduced locomotion and open arm entries in all groups, but Mp pre-treated rats exhibited increased motor coordination (p<0.01) and positive effects on the parallel beam (p<0.01) compared to paraquat and post-treated Mp groups.
Conclusions: Mp pre-treatment attenuates paraquat-induced PD symptoms, including anxiogenic responses, depleted 5-HT expression, and motor coordination, compared to post-treatment with Mp. Hence, early pharmacological intervention in PD management is promising, but safety assessments for Mp seed extract in neurodegenerative disorder treatment are crucial.

To cite this abstract in AMA style:

A. Obajuluwa, B. Laoye, J. Okwuaka, T. Obajuluwa, J. Lech, A. Oremosu. Pre-treatment with Methanolic Extract Mucuna pruriens Seeds Attenuates Serotonin Gene Depletion, Motor Dysfunction and Anxiogenic Responses in a Rat Model of Parkinsonism [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/pre-treatment-with-methanolic-extract-mucuna-pruriens-seeds-attenuates-serotonin-gene-depletion-motor-dysfunction-and-anxiogenic-responses-in-a-rat-model-of-parkinsonism/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pre-treatment-with-methanolic-extract-mucuna-pruriens-seeds-attenuates-serotonin-gene-depletion-motor-dysfunction-and-anxiogenic-responses-in-a-rat-model-of-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley